Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| EP ablation · Massachusetts | EP ablation · New York | |
|---|---|---|
| Surgeons, 2024 | 73 | 138 |
| Medicare fee-for-service cases | 4,222 | 7,854 |
| Growth since 2019 (Medicare FFS) | +12%/yr | +9.3%/yr |
| Forecast cases (Medicare FFS) | 9,560 in 2030 | 15,300 in 2030 |
| Forecast growth | +15%/yr to 2030 | +12%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.0 | 3.6 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 58 | 57 |
| Top 10 surgeons' share | 30% | 24% |
| Surgeons growing | 22 | 39 |
| New since the base year | 20 | 23 |
| Likely to stop billing it | 4 by 2026 | 5 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $12K | $8,514 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.